![Enroll in HiFlo COPD Study](http://hiflocopd.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![About HiFlo IMG About HiFlo](http://hiflocopd.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Human Respiratory System Anatomy About COPD - chronic inflammatory lung disease that can cause difficulty breathing, coughing, and wheezing](http://hiflocopd.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![About Clinical Trials](http://hiflocopd.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home – a multi-center randomized controlled trial](https://hiflocopd.com/wp-content/uploads/2021/11/myAirvo3-768x628.png)
myAirvo 3
High Flow Nasal Therapy for COPD Patients in the Home
Participate in the HiFlo phase III trial of home High Flow Nasal Therapy (HFNT) via myAirvo 3.
myAirvo 3 is a High Flow Nasal Therapy (HFNT) being offered to COPD patients via a clinical trial. The myAirvo 3 device is a humidifier with integrated flow generator that delivers warmed and humidified respiratory gases to the patient. Researchers are evaluating whether the device increases the time to when a patient experiences a COPD flareup, if it reduces flareup frequency, reduces hospitalization, improves quality of life, as well as other factors.